FINVX | NGRRX | FINVX / NGRRX | |
Total Expense Ratio | 0.01 | 0.90 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 1.06 | 1% |
Fund Existence | 16 years | 26 years | - |
Gain YTD | 34.480 | 27.214 | 127% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.2B | 150M | 10,800% |
Annual Yield % from dividends | 3.50 | 1.99 | 176% |
Returns for 1 year | 22.47 | 19.24 | 117% |
Returns for 3 years | 109.69 | 90.38 | 121% |
Returns for 5 years | 127.39 | 97.06 | 131% |
Returns for 10 years | 125.09 | 100.26 | 125% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSCPX | 352.54 | 3.39 | +0.97% |
Vanguard Small Cap Index InstlPlus | |||
ASMNX | 22.69 | 0.17 | +0.75% |
AQR Small Cap Momentum Style N | |||
LICRX | 17.59 | 0.09 | +0.51% |
Lord Abbett International Equity R3 | |||
SMFPX | 10.61 | N/A | N/A |
Westwood Salient MLP & Engy Infras C | |||
JFNSX | 65.08 | N/A | N/A |
Janus Henderson Global Life Sciences S |